ID

35258

Descripción

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection; ODM derived from: https://clinicaltrials.gov/show/NCT02243280

Link

https://clinicaltrials.gov/show/NCT02243280

Palabras clave

Versiones (1)
  1. 25/2/19 25/2/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

25 de febrero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Chronic Hepatitis C NCT02243280

Inglés

Eligibility Chronic Hepatitis C NCT02243280

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. male or female between 18 and 70 years of age, inclusive, at time of screening.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
2. screening laboratory result indicating hcv gt1, gt4, gt 5, or gt6 infection.
Descripción

Hepatitis C Genotype

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019196
UMLS CUI [1,2]
C0017431
3. chronic hcv infection.
Descripción

Hepatitis C, Chronic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0524910
4. subject must be either hcv treatment-naïve or combination of pegylated-interferon ribavirin experienced.
Descripción

Therapy naive Hepatitis C virus | PEGINTERFERON/RIBAVIRIN

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0919936
UMLS CUI [1,2]
C0220847
UMLS CUI [2]
C1875630
5. subjects must be documented as non-cirrhotic or cirrhotic.
Descripción

Study Subject Non-cirrhotic | Study Subject Cirrhotic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C0439687
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0439686
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. history of severe, life-threatening or other significant sensitivity to any drug.
Descripción

Drug Allergy Severe | Drug Allergy Life Threatening | Drug Allergy Significant

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013182
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0013182
UMLS CUI [2,2]
C2826244
UMLS CUI [3,1]
C0013182
UMLS CUI [3,2]
C0750502
2. female who is pregnant, planning to become pregnant during the study or breastfeeding; or male whose partner is pregnant or planning to become pregnant during the study.
Descripción

Pregnancy | Pregnancy, Planned | Breast Feeding | Gender Partner Pregnancy | Gender Partner Planned Pregnancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
UMLS CUI [3]
C0006147
UMLS CUI [4,1]
C0079399
UMLS CUI [4,2]
C0682323
UMLS CUI [4,3]
C0032961
UMLS CUI [5,1]
C0079399
UMLS CUI [5,2]
C0682323
UMLS CUI [5,3]
C0032992
3. recent (within 6 months prior to study drug administration) history of drug or alcohol abuse that could preclude adherence to the protocol in the opinion of the investigator.
Descripción

Substance Use Disorders Exclude Protocol Compliance

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0038586
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0525058
4. positive test result at screening for hepatitis b surface antigen (hbsag) or anti-human immunodeficiency virus antibody (hiv ab).
Descripción

Hepatitis B surface antigen positive | HIV antibody positive

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0149709
UMLS CUI [2]
C0920548
5. hcv genotype performed during screening indicating co-infection with more than one hcv genotype.
Descripción

HCV coinfection Genotype Quantity | Hepatitis C virus genotype determination

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1698259
UMLS CUI [1,2]
C0017431
UMLS CUI [1,3]
C1265611
UMLS CUI [2]
C1533728
Volver a la parte superior de la página

Similar models

Eligibility Chronic Hepatitis C NCT02243280

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
1. male or female between 18 and 70 years of age, inclusive, at time of screening.
boolean
C0001779 (UMLS CUI [1])
Hepatitis C Genotype
Item
2. screening laboratory result indicating hcv gt1, gt4, gt 5, or gt6 infection.
boolean
C0019196 (UMLS CUI [1,1])
C0017431 (UMLS CUI [1,2])
Hepatitis C, Chronic
Item
3. chronic hcv infection.
boolean
C0524910 (UMLS CUI [1])
Therapy naive Hepatitis C virus | PEGINTERFERON/RIBAVIRIN
Item
4. subject must be either hcv treatment-naïve or combination of pegylated-interferon ribavirin experienced.
boolean
C0919936 (UMLS CUI [1,1])
C0220847 (UMLS CUI [1,2])
C1875630 (UMLS CUI [2])
Study Subject Non-cirrhotic | Study Subject Cirrhotic
Item
5. subjects must be documented as non-cirrhotic or cirrhotic.
boolean
C0681850 (UMLS CUI [1,1])
C0439687 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0439686 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Drug Allergy Severe | Drug Allergy Life Threatening | Drug Allergy Significant
Item
1. history of severe, life-threatening or other significant sensitivity to any drug.
boolean
C0013182 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0013182 (UMLS CUI [2,1])
C2826244 (UMLS CUI [2,2])
C0013182 (UMLS CUI [3,1])
C0750502 (UMLS CUI [3,2])
Pregnancy | Pregnancy, Planned | Breast Feeding | Gender Partner Pregnancy | Gender Partner Planned Pregnancy
Item
2. female who is pregnant, planning to become pregnant during the study or breastfeeding; or male whose partner is pregnant or planning to become pregnant during the study.
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0079399 (UMLS CUI [4,1])
C0682323 (UMLS CUI [4,2])
C0032961 (UMLS CUI [4,3])
C0079399 (UMLS CUI [5,1])
C0682323 (UMLS CUI [5,2])
C0032992 (UMLS CUI [5,3])
Substance Use Disorders Exclude Protocol Compliance
Item
3. recent (within 6 months prior to study drug administration) history of drug or alcohol abuse that could preclude adherence to the protocol in the opinion of the investigator.
boolean
C0038586 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
Hepatitis B surface antigen positive | HIV antibody positive
Item
4. positive test result at screening for hepatitis b surface antigen (hbsag) or anti-human immunodeficiency virus antibody (hiv ab).
boolean
C0149709 (UMLS CUI [1])
C0920548 (UMLS CUI [2])
HCV coinfection Genotype Quantity | Hepatitis C virus genotype determination
Item
5. hcv genotype performed during screening indicating co-infection with more than one hcv genotype.
boolean
C1698259 (UMLS CUI [1,1])
C0017431 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C1533728 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial